Conditions | Yield |
---|---|
With sodium hydroxide In methanol at 50℃; for 0.5h; | 98% |
With potassium hydroxide In ethanol | 83% |
With potassium hydroxide In ethanol at 50℃; | 83% |
With potassium hydroxide In ethanol for 0.166667h; Heating; | 71% |
Conditions | Yield |
---|---|
With tris(triphenylphosphine)ruthenium(II) chloride; oxygen; bis-(3-methyl-1-imidazolyl)ethylene tetrafluoroborate In hexane at 50℃; under 760.051 Torr; for 3h; Reagent/catalyst; Darkness; | 90.2% |
Multi-step reaction with 2 steps 1: MnO2 / CH2Cl2 / 2 h / Ambient temperature 2: 80 percent / AgO, NaCN / methanol / 18 h / Ambient temperature View Scheme | |
Multi-step reaction with 2 steps 1: 90 percent / MnO2 / CH2Cl2 / Ambient temperature 2: AgO / CNNa / methanol View Scheme |
(6R,7R)-3-[(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoyloxymethyl]-5,8-dioxo-7-(2-phenoxy-acetylamino)-5λ4-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
A
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With β-lactamase from Staphylococcus aureus 95; deuterated phosphate buffer In dimethylsulfoxide-d6 at 25℃; pH=7.2; | A n/a B 86% |
trans-β-formyl crotonic acid
all-trans-retinoic-acid
Conditions | Yield |
---|---|
Stage #1: trans-β-formyl crotonic acid; [3-methyl-5-(2,6,6-trimethylcyclohexene-1-yl)-2E,4E-pentadiene]-triphenyl phosphonic chloride With potassium hydroxide In isopropyl alcohol at -5 - 0℃; for 2h; Wittig Olefination; Inert atmosphere; Stage #2: With hydrogenchloride; palladium diacetate In isopropyl alcohol at 50℃; pH=7 - 8; pH-value; Reagent/catalyst; Temperature; | 85.3% |
trans-β-formyl crotonic acid
[(2E,4E)-3-methyl-5-(2,6,6-trimethylcyclohex-1-en-1-yl)penta-2,4-dienyl]triphenylphosphonium chloride
all-trans-retinoic-acid
Conditions | Yield |
---|---|
Stage #1: trans-β-formyl crotonic acid; [(2E,4E)-3-methyl-5-(2,6,6-trimethylcyclohex-1-en-1-yl)penta-2,4-dienyl]triphenylphosphonium chloride With potassium hydroxide In isopropyl alcohol at -5 - 0℃; for 2h; Wittig Olefination; Inert atmosphere; Stage #2: With hydrogenchloride; palladium diacetate In isopropyl alcohol at 50℃; pH=7-8; Reagent/catalyst; Temperature; pH-value; Inert atmosphere; | 85.3% |
Conditions | Yield |
---|---|
With silver(II) oxide; sodium cyanide In methanol for 18h; Ambient temperature; | 80% |
With sodium cyanide; silver(l) oxide | 80% |
With silver(II) oxide; sodium cyanide In methanol Yield given; |
Conditions | Yield |
---|---|
With potassium hydroxide In ethanol for 0.5h; Heating; Yield given; | A n/a B 77% |
With potassium hydroxide In ethanol for 0.5h; Heating; Yields of byproduct given; | A n/a B 77% |
(2E,4E)-5-iodo-3-methylpenta-2,4-dienoic acid
all-trans-retinoic-acid
Conditions | Yield |
---|---|
[PdCl2(NCMe)2] In N,N-dimethyl-formamide at 25℃; for 3h; Stille cross-coupling reaction; | 73% |
acide-2-carboxy-3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2E,4E,6E,8E-tetraenoique
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With pyridine In dichloromethane | 67% |
5-(2,6,6-trimethyl-cyclohex-1-enyl)-3-methyl-1-phenyl-sulphonyl-penta-2,4-diene
(E)-4-bromo-3-methyl-2-butenoic acid
all-trans-retinoic-acid
Conditions | Yield |
---|---|
Stage #1: 5-(2,6,6-trimethyl-cyclohex-1-enyl)-3-methyl-1-phenyl-sulphonyl-penta-2,4-diene With potassium tert-butylate In tetrahydrofuran at -20℃; for 0.5h; Stage #2: (E)-4-bromo-3-methyl-2-butenoic acid In tetrahydrofuran at -20 - 60℃; for 4h; Julia olefination; | 65% |
β-ionone
methylmagnesium bromide
dimethyl 2-[(2E)-3-(dimethylamino)-1-methyl-2-propenylidene]malonate
A
13-cis-retinoic acid
B
all-trans-retinoic-acid
Conditions | Yield |
---|---|
Multistep reaction.; | A 12% B 61% |
acide-2-carboxy-3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2E,4E,6E,8E-tetraenoique
A
13-cis-retinoic acid
B
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With pyridine In dichloromethane at 20℃; for 20h; | A n/a B 60% |
With barium dihydroxide In benzene for 0.5h; |
Conditions | Yield |
---|---|
With phosphoric acid In 1,4-dioxane; ethanol; hexane | 55.9% |
all-trans-retinoic-acid
Conditions | Yield |
---|---|
Stage #1: [(2Z,4E)-3-methyl-5-(2,6,6-trimethylcyclohex-1-en-1-yl)penta-2,4-dienyl]triphenylphosphonium chloride With sodium methylate In methanol at -7.5℃; for 1h; Wittig Reaction; Stage #2: With methanol; sodium hydroxide; ethanol; water at 20℃; Heating / reflux; Stage #3: With water; acetic acid In dichloromethane | 46% |
Conditions | Yield |
---|---|
With potassium hydroxide In ethanol; water for 2h; Heating; | A 38% B n/a |
retinoyl fluoride
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With water In isopropyl alcohol for 23h; | 38% |
(2E,4E,6E,8E)-3,7-dimethyl-9-{6,6-dimethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)-1-cyclohexenyl}-2,4,6,8-nonatetraenoicacid ethyl ester
methyl iodide
A
13-cis-retinoic acid
C
all-trans-retinoic-acid
Conditions | Yield |
---|---|
Stage #1: (2E,4E,6E,8E)-3,7-dimethyl-9-{6,6-dimethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)-1-cyclohexenyl}-2,4,6,8-nonatetraenoicacid ethyl ester; methyl iodide With tris-(dibenzylideneacetone)dipalladium(0); potassium carbonate; tris-(o-tolyl)phosphine In water; N,N-dimethyl-formamide at 60℃; for 0.0833333h; Inert atmosphere; Schlenk technique; Stage #2: With potassium hydroxide In methanol; water; N,N-dimethyl-formamide at 100℃; for 0.0333333h; Inert atmosphere; Schlenk technique; Stage #3: With formic acid In methanol; water; N,N-dimethyl-formamide Inert atmosphere; Schlenk technique; | A 10% B 0.5% C 32% |
trans-β-formyl crotonic acid
(1E)-1-(2,6,6-trimethylcyclohex-1-enyl)-3-methyl-1,4-pentadien-3-ol
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With triphenylphosphine |
ethyl 3-methylbut-2-enoate
(2E,4E)-3-methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-pentadienal
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With potassium amide |
(+/-)-7-hydroxy-3.7-dimethyl-1t-(2.2.6-trimethyl-cyclohexen-(6)-yl)-nonatrien-(1.3t.5t)-oic acid-(9)-ethyl ester
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With iodine; Petroleum ether Behandeln des erhaltenen all-trans-Retinsaeure-aethylesters mit wss.-aethanol. Kalilauge unter Stickstoff bei Lichtausschluss; |
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With oxalic acid unter vermindertem Druck und Behandeln mit methanol. oder aethanol. Kalilauge; | |
With toluene-4-sulfonic acid; benzene Behandeln mit methanol. oder aethanol. Kalilauge; | |
With phenyl isocyanate at 110℃; Behandeln mit methanol. oder aethanol. Kalilauge; |
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With iodine |
methyl 5-benzenesulphonyl-3.7-dimethyl-9-(2'.6'.6'.trimethyl-cyclohexen-1'-yl)-2.6.8-nonatrienoate
A
13-cis-retinoic acid
B
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With potassium hydroxide In methanol for 2.5h; Heating; Yield given. Yields of byproduct given; |
8-<2-(methylthio)-1,3-dithian-2-yl>-3,7-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)octa-1E,3E,5E,7E-tetraene
A
13-cis-retinoic acid
B
all-trans-retinoic-acid
Conditions | Yield |
---|---|
Yield given. Multistep reaction. Yields of byproduct given; |
(2E,4E,8E/2Z,4E,8E)-7-hydroxy-7-methyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-nona-2,4,8-trienoic acid
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With iodine; toluene-4-sulfonic acid 1.) methylene dichloride, reflux; 2.) diethyl ether/benzene, rt, 7 h; Yield given; | |
Multi-step reaction with 2 steps 1: 95 percent / p-toluenesulfonic acid / CH2Cl2 / Heating 2: I2 View Scheme |
(E)-2-(but-1-en-3-ynyl)-1,3,3-trimethylcyclohex-1-ene
(2E,4E)-5-iodo-3-methylpenta-2,4-dienoic acid
methyl iodide
all-trans-retinoic-acid
Conditions | Yield |
---|---|
Yield given. Multistep reaction; |
all-trans-Retinal
A
all-trans-retinoic-acid
B
4-hydroxy-all-trans-retinal
Conditions | Yield |
---|---|
With rabbit liver microsomal P450 1A1 isozyme; NADPH; NADPH-cytochrome P450 reductase In phosphate buffer at 30℃; for 0.25h; pH=7.4; Enzyme kinetics; Further Variations:; Reaction partners; Oxidation; Enzymatic reaction; |
Conditions | Yield |
---|---|
With triphenylphosphine |
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With triphenylphosphine |
all-trans-retinoic-acid
diazomethyl-trimethyl-silane
all-trans-methyl retinoate
Conditions | Yield |
---|---|
In methanol; hexane; benzene at 20℃; for 0.75h; | 100% |
With methanol In benzene at 20℃; Methylation; |
Conditions | Yield |
---|---|
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 0℃; for 24h; optical yield given as %de; | 99% |
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With palladium 10% on activated carbon; hydrogen In methanol at 20℃; under 760.051 Torr; | 99% |
all-trans-retinoic-acid
1,1'-carbonyldiimidazole
N-(all-trans-Retinoyl)-imidazole
Conditions | Yield |
---|---|
In acetonitrile for 1h; Heating; | 98.6% |
In N,N-dimethyl-formamide Ambient temperature; | 80% |
In benzene at 20℃; for 1h; | 60% |
all-trans-retinoic-acid
3-(tert-butyldisulfanyl)propane-1,2-diol
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid 2-tert-butyldisulfanyl-1-[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoyloxymethyl]-ethyl ester
Conditions | Yield |
---|---|
With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran for 12h; Ambient temperature; | 98% |
Chloromethyl pivalate
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide at 70℃; for 3h; Alkylation; | 98% |
Conditions | Yield |
---|---|
With diethyl cyanophosphonate; triethylamine In tetrahydrofuran | 98% |
all-trans-retinoic-acid
(+)-octan-2-ol
(+)-2-octanoyl retinoate
Conditions | Yield |
---|---|
With dicyclohexyl-carbodiimide In diethyl ether 1.) 0 deg C, 30 min, 2.) 25 deg C, 1 h; | 96% |
Conditions | Yield |
---|---|
With thionyl chloride; triethylamine In N,N-dimethyl-formamide | 96% |
Conditions | Yield |
---|---|
With dicyclohexyl-carbodiimide In diethyl ether 1.) 0 deg C, 30 min, 2.) 25 deg C, 1 h; | 95% |
(i) N,N'-carbonyl-di-imidazole, (ii) /BRN= 1718733/, NaOEt; Multistep reaction; |
1,1'-Carbonyl-di-(1,2,4-triazole)
all-trans-retinoic-acid
Conditions | Yield |
---|---|
In acetonitrile for 1h; Heating; | 95% |
In N,N-dimethyl-formamide 1.) RT; 15 min, 2.) 40 deg C, 4 h; | 87% |
all-trans-retinoic-acid
(+)-α-phenethyl alcohol
(+)-α-phenethylretinoate
Conditions | Yield |
---|---|
With dicyclohexyl-carbodiimide In diethyl ether 1.) 0 deg C, 30 min, 2.) 25 deg C, 1 h; | 95% |
all-trans-retinoic-acid
(-)-α-phenethyl alcohol
(-)-α-phenethylretinoate
Conditions | Yield |
---|---|
With dicyclohexyl-carbodiimide In diethyl ether 1.) 0 deg C, 30 min, 2.) 25 deg C, 1 h; | 95% |
all-trans-retinoic-acid
2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide
all-trans-retinoic acid-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosylester
Conditions | Yield |
---|---|
With pyridine; silver(l) oxide for 1.5h; | 95% |
chloromethyl isobutyrate
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide at 70℃; for 3h; Alkylation; | 94% |
Conditions | Yield |
---|---|
With bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)]} In dichloromethane at 20℃; for 0.166667h; Inert atmosphere; | 93% |
all-trans-retinoic-acid
Conditions | Yield |
---|---|
With tert-butylimino-tri(pyrrolidino)phosphorane In dichloromethane at 30℃; for 0.166667h; Schlenk technique; | 93% |
all-trans-retinoic-acid
(2-bromoethyl)(hexyl)(2-hydroxyethyl)phosphate
2-((2-bromoethoxy)(hexyloxy)phosphoryl)ethoxyretinoate
Conditions | Yield |
---|---|
With dmap; N-ethyl-N,N-diisopropylamine; chlorotri(pyrrolidin-1-yl)phosphonium hexafluorophosphate In dichloromethane for 24h; Inert atmosphere; Reflux; | 92% |
With dmap; N-ethyl-N,N-diisopropylamine; chlorotri(pyrrolidin-1-yl)phosphonium hexafluorophosphate In dichloromethane for 24h; Reflux; Inert atmosphere; | 92% |
all-trans-retinoic-acid
propargyl bromide
(2E,4E,6E,8E)-prop-2-yn-1-yl 3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoate
Conditions | Yield |
---|---|
With caesium carbonate In tetrahydrofuran at 20℃; for 1h; | 92% |
With caesium carbonate In tetrahydrofuran at 20℃; | 89% |
Conditions | Yield |
---|---|
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 0 - 20℃; for 2h; Inert atmosphere; | 92% |
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 0 - 20℃; for 2h; Inert atmosphere; |
all-trans-retinoic-acid
4-hydroxy-benzaldehyde
4-formylphenyl(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoate
Conditions | Yield |
---|---|
With dmap; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 20℃; for 24h; | 91% |
With dmap; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 20℃; for 24h; | 91% |
Conditions | Yield |
---|---|
Stage #1: all-trans-retinoic-acid With 1-hydroxy-pyrrolidine-2,5-dione; dicyclohexyl-carbodiimide In dimethyl sulfoxide at 20℃; for 20h; Stage #2: ethylenediamine In dimethyl sulfoxide at 20℃; for 24h; | 91% |
Stage #1: all-trans-retinoic-acid With 1-hydroxy-pyrrolidine-2,5-dione; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane Cooling with ice; Stage #2: ethylenediamine In dichloromethane at 20℃; | 63% |
all-trans-retinoic-acid
retinoyl fluoride
Conditions | Yield |
---|---|
With (2-chloro-1,2,2-trifluoro-ethyl)-diethyl-amine In tetrahydrofuran for 0.25h; Heating; | 90% |
With perfluoropropylene; diethylamine | |
With diethylamino-sulfur trifluoride In diethyl ether 1.) -70 deg C, 60 min, 2.) r.t., 2 h; | 9.1 g |
all-trans-retinoic-acid
methyl (2S)-2-amino-3-phenylpropanoate
N-(all-trans-retinoyl)-L-phenylalanine methyl ester
Conditions | Yield |
---|---|
With dmap; dicyclohexyl-carbodiimide In dichloromethane for 0.5h; Ambient temperature; | 90% |
Conditions | Yield |
---|---|
With sodium chloride; argon In ethyl acetate; N,N-dimethyl-formamide | 90% |
With sodium chloride In ethyl acetate; N,N-dimethyl-formamide | 90% |
1-hydroxy-pyrrolidine-2,5-dione
all-trans-retinoic-acid
N-(all-trans-Retinoyloxy)-succinimide
Conditions | Yield |
---|---|
With dicyclohexyl-carbodiimide In tetrahydrofuran at 0 - 20℃; Inert atmosphere; Darkness; | 90% |
With dicyclohexyl-carbodiimide In tetrahydrofuran at 0 - 25℃; for 0.208333h; | 73% |
With dicyclohexyl-carbodiimide In dimethyl sulfoxide at 20℃; for 72h; | |
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; dmap In dichloromethane at 20℃; for 3h; | |
With dicyclohexyl-carbodiimide In tetrahydrofuran at 0 - 20℃; |
all-trans-retinoic-acid
3-Hydroxypropionitrile
(2E,4E,6E,8E)-2-cyanoethyl 3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoate
Conditions | Yield |
---|---|
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 18h; | 90% |
Conditions | Yield |
---|---|
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane at 20℃; Inert atmosphere; | 90% |
Reported in EPA TSCA Inventory. EPA Genetic Toxicology Program.
The Tretinoin, with the CAS registry number 302-79-4,is also known as 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; all-trans-Retinoic acid; Vitamin A acid. It belongs to the product categories of Intermediates & Fine Chemicals;Retinoids;Intracellular receptor;API.Its EINECS number is 206-129-0. This chemical's molecular formula is C20H28O2 and molecular weight is 300.44. What's more,Its systematic name is Tretinoin.It is a yellow-orange powder which has been used to treat acne and other skin problems, and can be used for the unusual type of acne, psoriasis ichthyosis and abnormal.
Physical properties about Tretinoin are:
(1)ACD/LogP: 6.83; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): 5.99; (4)ACD/LogD (pH 7.4): 4.19; (5)ACD/BCF (pH 5.5): 13226.03; (6)ACD/BCF (pH 7.4): 210.25; (7)ACD/KOC (pH 5.5): 17912.95; (8)ACD/KOC (pH 7.4): 284.76; (9)#H bond acceptors: 2; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 5; (12)Index of Refraction: 1.556; (13)Molar Refractivity: 95.527 cm3; (14)Molar Volume: 297.151 cm3; (15)Surface Tension: 39.1399993896484 dyne/cm; (16)Density: 1.011 g/cm3; (17)Flash Point: 350.596 °C; (18)Enthalpy of Vaporization: 79.324 kJ/mol; (19)Boiling Point: 462.801 °C at 760 mmHg; (20)Vapour Pressure: 0 mmHg at 25°C.3. Structure Descriptors of Tretinoin
You can still convert the following datas into molecular structure:
(1)SMILES:O=C(O)\C=C(\C=C\C=C(\C=C\C1=C(\CCCC1(C)C)C)C)C;
(2)Std. InChI:InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+;
(3)Std. InChIKey:SHGAZHPCJJPHSC-YCNIQYBTSA-N.
Safety Information of Tretinoin:
The Tretinoin is harmful by inhalation, in contact with skin and if swallowed and rritating to skin. It is possible risk of harm to the unborn child. In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) .When you use it wear suitable protective clothing, gloves and eye/face protection. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. This chemical is danger to the environment Avoid exposure - obtain special instructions before use.
Toxicity of Tretinoin is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 208mg/kg (208mg/kg) | Drugs in Japan Vol. -, Pg. 886, 1995. | |
mouse | LD50 | intravenous | 92mg/kg (92mg/kg) | United States Patent Document. Vol. #3878202, | |
mouse | LD50 | oral | 1100mg/kg (1100mg/kg) | American Journal of Clinical Nutrition. Vol. 52, Pg. 183, 1990. | |
mouse | LD50 | subcutaneous | 253mg/kg (253mg/kg) | BEHAVIORAL: SLEEP LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 3194, 1973. |
rat | LD50 | intraperitoneal | 96mg/kg (96mg/kg) | SPINAL CORD: OTHER DEGENERATIVE CHANGES BEHAVIORAL: ATAXIA BLOOD: NORMOCYTIC ANEMIA | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 3194, 1973. |
rat | LD50 | intravenous | 75mg/kg (75mg/kg) | Drugs in Japan Vol. -, Pg. 886, 1995. | |
rat | LD50 | oral | 2gm/kg (2000mg/kg) | American Journal of Clinical Nutrition. Vol. 52, Pg. 183, 1990. | |
rat | LD50 | subcutaneous | 53mg/kg (53mg/kg) | BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 3194, 1973. |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View